Corcoran Andrea
Insider CIK 1296996 · AVIR See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2026-03-11 | 2026-03-13 | 60,000 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2026-03-11 | 2026-03-13 | 60,000 | $1.24 | $74.4K | 823,576 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2026-01-31 | 2026-02-03 | 10,500 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2026-01-31 | 2026-02-03 | 44,366 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2026-01-31 | 2026-02-03 | 180,000 | — | $0 | 180,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | F Tax w/h | 2026-01-31 | 2026-02-03 | 16,104 | $4.24 | $68.3K | 763,576 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2026-01-31 | 2026-02-03 | 54,866 | — | $0 | 779,680 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 10,500 | — | $0 | 10,500 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2025-01-31 | 2025-02-04 | 44,367 | — | $0 | 44,366 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2025-01-31 | 2025-02-04 | 44,367 | — | $0 | 722,909 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award | 2025-01-31 | 2025-02-04 | 10,500 | — | $0 | 733,409 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | F Tax w/h | 2025-01-31 | 2025-02-04 | 16,102 | $3.06 | $49.3K | 717,307 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 15,843 | $3.84 | $60.8K | 670,208 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2024-01-31 | 2024-02-02 | 44,367 | — | $0 | 88,733 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2024-01-31 | 2024-02-02 | 44,367 | — | $0 | 686,051 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 133,100 | — | $0 | 133,100 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 186,300 | — | $0 | 186,300 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 181,000 | — | $0 | 181,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2021-01-29 | 2021-02-01 | 148,850 | — | $0 | 148,850 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion deriv | 2020-11-03 | 2020-11-03 | 100,000 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion deriv | 2020-11-03 | 2020-11-03 | 33,004 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion | 2020-11-03 | 2020-11-03 | 133,004 | — | $0 | 633,004 | SEC↗ |